Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesPreferred Shares IssuedShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Opus Genetics (IRD) Other financing activities (2020 - 2026)

Opus Genetics has reported Other financing activities over the past 7 years, most recently at $100000.0 for Q1 2026.

  • Quarterly Other financing activities fell 92.92% to $100000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $455000.0 through Mar 2026, down 71.28% year-over-year, with the annual reading at $2.3 million for FY2025, 891.81% up from the prior year.
  • Other financing activities was $100000.0 for Q1 2026 at Opus Genetics, up from $98000.0 in the prior quarter.
  • Over five years, Other financing activities peaked at $1.4 million in Q1 2025 and troughed at $12000.0 in Q4 2022.
  • The 5-year median for Other financing activities is $98000.0 (2025), against an average of $173933.3.
  • Year-over-year, Other financing activities tumbled 93.81% in 2022 and then soared 2216.39% in 2025.
  • A 5-year view of Other financing activities shows it stood at $12000.0 in 2022, then soared by 1333.33% to $172000.0 in 2023, then crashed by 73.26% to $46000.0 in 2024, then surged by 113.04% to $98000.0 in 2025, then increased by 2.04% to $100000.0 in 2026.
  • Per Business Quant, the three most recent readings for IRD's Other financing activities are $100000.0 (Q1 2026), $98000.0 (Q4 2025), and $100000.0 (Q3 2025).